Which microbial factors really are important in Pseudomonas aeruginosa infections?

Future Microbiology

Volumn 10, Issue 11, 2015, Pages 1825-1836

  Crousilles, Audrey ^a   Maunders, Eve ^a   Bartlett, Sean ^b   Fan, Catherine ^a   Ukor, Emem Fong ^c   Abdelhamid, Yassmin ^a   Baker, Ysobel ^b   Floto, Andres ^c   Spring, David R ^b   Welch, Martin ^a  

^a Hopkins Building   (United Kingdom)

^b Department of Chemistry ^*  (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

antimicrobial agents; cystic fibrosis; infection; metabolism; Pseudomonas aeruginosa; RNASeq; TnSeq; virulence

Indexed keywords

GLYOXYLIC ACID; ISOCITRATE LYASE; MALATE SYNTHASE; PROTEINASE; TRICARBOXYLIC ACID; VIRULENCE FACTOR;

BACTERIAL GENE; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BIOFILM; CITRIC ACID CYCLE; HISTORY; MONTE CARLO METHOD; NONHUMAN; OPEN READING FRAME; PATHOGENICITY; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; REVIEW; RNA SEQUENCE; TRANSPOSON; TYPE I SECRETION SYSTEM; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; VIRULENCE;

HOST-PATHOGEN INTERACTIONS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MUTAGENESIS, INSERTIONAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE; VIRULENCE FACTORS;

EID: 84948134623     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.100     Document Type: Review

References (53)

1. Foweraker J. Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. Br. Med. Bull. 89, 93-110 (2009).
2. Stover CK, Pham XQ, Erwin AL et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406, 959-964 (2000).
3. Hoge R, Pelzer A, Rosenau F, Wilhelm S. Weapons of a pathogen: proteases and their role in virulence of Pseudomonas aeruginosa. In: Current Research: Technology And Education Topics In Applied Microbiology And Microbial Biotechnology. Mendez-Vilas A (Ed.).
4. Passmore IJ, Nishikawa K, Lilley KS et al. Mep72, a metzincin protease that is preferentially secreted by biofilms of Pseudomonas aeruginosa. J. Bacteriol. 197, 762-773 (2015).
5. Nouwens AS, Beatson SA, Whitchurch CB et al. Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1. Microbiology 149, 1311-1322 (2003).
6. Pearson JP, Pesci EC, Iglewski BH. Roles of Pseudomonas aeruginosa las and rhl quorumsensing systems in control of elastase and rhamnolipid biosynthesis genes. J. Bacteriol 179, 5756-5767 (1997).
7. Pearson JP, Feldman M, Iglewski BH, Prince A. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection. Infect Immun. 68, 4331-4 (2000).
8. Rumbaugh KP, Griswold JA, Iglewski BH, Hamood AN. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect Immun. 67, 5854-5862 (1999).
9. Goodman AL, Kulasekara B, Rietsch A et al. A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev Cell 7, 745-754 (2004).
10. Ventre I, Goodman AL, Vallet-Gely I et al. Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc. Natl Acad. Sci. USA 103, 171-176 (2006).
11. D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol. Microbiol. 64, 512-533 (2007).
12. Smith EE, Buckley DG, Wu Z, Saenphimmachak C et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl Acad. Sci. USA 103, 8487-8492 (2006).
13. van Opijnen T, Bodi KL, Camilli A. Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat. Methods 6, 767-772 (2009).
14. Turner KH, Everett J, Trivedi U et al. Requirements for Pseudomonas aeruginosa acute burn and chronic surgical wound infection. PLoS Genet. 10(7), e1004518 (2014).
15. Jackson KD, Starkey M, Kremer S et al. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J. Bacteriol. 186, 4466-4475 (2004).
16. Palmer KL, Aye LM, Whiteley M. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189, 8079-8087 (2007).
17. Sato S, Hayashi M, Imamura S et al. Primary structures of the genes, faoA and faoB, from Pseudomonas fragi B-0771 which encode the two subunits of the HDT multienzyme complex involved in fatty acid beta-oxidation. J. Biochem. 111, 8-15 (1992).
18. Cozzone AJ. Regulation of acetate metabolism by protein phosphorylation in enteric bacteria. Annu Rev Microbiol. 52, 127-164 (1998).
19. de la Pena Mattozzi M, Kang Y, Keasling Feast JD. Choking on acetyl-CoA, the glyoxylate shunt, and acetyl-CoA-driven metabolism. In: Handbook of Hydrocarbon and Lipid Microbiology. Timmis KN (Ed.). Springer-Verlag, Berlin, Heidelberg (2010).
20. Lindsey TL, Hagins JM, Sokol PA, Silo-Suh LA. Virulence determinants from a cystic fibrosis isolate of Pseudomonas aeruginosa include isocitrate lyase. Microbiology 154, 1616-1627 (2008).
21. Fahnoe KC, Flanagan ME, Gibson G et al. Non-traditional antibacterial screening approaches for the identification of novel inhibitors of the glyoxylate shunt in gram-negative pathogens. PLoS ONE 7(12), e51732 (2012).
22. Ménage S, Attreé I. Metabolism: pathogens love the poison. Nat. Chem. Biol. 10, 326-327 (2014).
23. Sasikaran J, Ziemski M, Zadora PK et al. Bacterial itaconate degradation promotes pathogenicity. Nat. Chem. Biol. 10, 371-377 (2014).
24. Vercammen K, Wei Q, Charlier D et al. Pseudomonas aeruginosa LysR PA4203 regulator NmoR acts as a repressor of the PA4202 nmoA gene, encoding a nitronate monooxygenase. J. Bacteriol. 197, 1026-1039 (2015).
25. Berger A, Dohnt K, Tielen P, Jahn D, Becker J, Wittmann C. Robustness and plasticity of metabolic pathway flux among uropathogenic isolates of Pseudomonas aeruginosa. PLoS ONE 9(4), e88368 (2014).
26. Chung JC, Rzhepishevska O, Ramstedt M, Welch M. Type III secretion system expression in oxygen-limited Pseudomonas aeruginosa cultures is stimulated by isocitrate lyase activity. Open Biol. 3, 120131 (2013).
27. Trunk K, Benkert B, Quäck N et al. Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons. Environ. Microbiol. 12, 1719-1733 (2010).
28. Daniels JB, Scoffield J, Woolnough JL, Silo-Suh L. Impact of glycerol-3-phosphate dehydrogenase on virulence factor production by Pseudomonas aeruginosa. Can. J. Microbiol. 60, 857-863 (2014).
29. Turner KH, Wessel AK, Palmer GC et al. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum. Proc. Natl Acad. Sci. USA 112, 4110-5 (2015)
30. Barth AL, Pitt TL. Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J. Clin. Microbiol. 33, 37-40 (1995).
31. Barth AL, Pitt TL. The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J. Med. Microbiol. 45, 110-119 (1996).
32. Thomas SR, Ray A, Hodson ME, Pitt TL. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55, 795-797 (2000).
33. Patell S, Gu M, Davenport P, Givskov M, Waite RD, Welch M. Comparative microarray analysis reveals that the core biofilm-associated transcriptome of Pseudomonas aeruginosa comprises relatively few genes. Environ. Microbiol. Rep. 2, 440-448 (2010).
34. Rainey PB, Rainey K. Evolution of cooperation and conflict in experimental bacterial populations. Nature 425, 72-74 (2003).
35. Diggle SP, Griffin AS, Campbell GS, West SA. Cooperation and conflict in quorumsensing bacterial populations. Nature 450, 411-414 (2007).
36. Chung JC, Becq J, Fraser L et al. Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J. Bacteriol. 194, 4857-4866 (2012).
37. Williams D, Evans B, Haldenby S et al. Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections. Am. J. Respir. Crit. Care Med. 191, 775-785 (2015).
38. Mowat E, Paterson S, Fothergill JL et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am. J. Respir. Crit. Care Med. 183, 1674-1679 (2011).
39. Foweraker JE, Laughton CR, Brown DF, Bilton D. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. J. Antimicrob. Chemother. 55, 921-927 (2005).
40. Twomey KB, Alston M, An SQ et al. Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation. PLoS ONE 8, e82432 (2013).
41. Lynch SV, Bruce KD. The cystic fibrosis airway microbiome. Cold Spring Harb. Perspect. Med. 3, a009738 (2013).
42. Traxler MF, Summers SM, Nguyen HT et al. The global, ppGpp-mediated stringent response to amino acid starvation in Escherichia coli. Mol. Microbiol. 68, 1128-1148 (2008).
43. Dalebroux ZD, Svensson SL, Gaynor EC, Swanson MS. ppGpp conjures bacterial virulence. Microbiol. Mol. Biol. Rev. 74, 171-199 (2010).
44. Bowden SD, Eyres A, Chung JC et al. Virulence in Pectobacterium atrosepticum is regulated by a coincidence circuit involving quorum sensing and the stress alarmone, (p) ppGpp. Mol. Microbiol. 90, 457-471 (2013).
45. Moscoso JA, Mikkelsen H, Heeb S et al. The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling. Environ. Microbiol. 13, 3128-3138 (2011).
46. Lee SA, Gallagher LA, Thongdee M et al. General and condition-specific essential functions of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 112, 5189-5194 (2015).
47. Brencic A, McFarland KA, McManus HR et al. The GacS/GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs. Mol. Microbiol. 73, 434-445 (2009).
48. Filloux A, Michel G, Bally M. GSPdependent protein secretion in Gram-negative bacteria: the Xcp system of Pseudomonas aeruginosa. FEMS Microbiol. Rev. 22, 177-198 (1998).
49. Ball G, Durand E, Lazdunski A, Filloux A. A novel type II secretion system in Pseudomonas aeruginosa. Mol. Microbiol. 43, 475-485 (2002).
50. Bleves S, Viarre V, Salacha R, Michel GP, Filloux A, Voulhoux R. Protein secretion systems in Pseudomonas aeruginosa: a wealth of pathogenic weapons. Int. J. Med. Microbiol. 300, 534-543 (2010).
51. Filloux A. Protein secretion systems in Pseudomonas aeruginosa: an essay on diversity, evolution, and function. Front. Microbiol. 2, 155 (2011).
52. Franklin MJ, Nivens DE, Weadge JT, Howell PL. Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl. Front. Microbiol. 2, 167 (2011).
53. LaPorte DC, Koshland DE Jr. Phosphorylation of isocitrate dehydrogenase as a demonstration of enhanced sensitivity in covalent modification. Nature 305 , 286-290 (1983).